FRC
FRC Logo
Sign InGet Access

Connect With Us

Stay updated with our latest research and insights

Fundamental Research Corp Logo

Highly ranked equity research firm providing institutional grade tools and analysis to all investors worldwide. Trusted by global investors for over 20+ years.

20+ Years
Rate us on TrustpilotLeave a review

Policies

  • Privacy Policy
  • Terms of Service
  • Disclaimer

Company

  • About Us
  • Our Team
  • Contact Us
  • Leave a Review

Resources

  • Videos
  • Research Reports
  • FAQ
  • How to use FRC

Browse

  • Stock Directory
  • Stock Screener
  • Market Intel Weekly
  • Report Archive

Trackers

  • Congress Trading
  • Senate Trading
  • Congress Net Worth
  • Commodities

© 2026 Fundamental Research Corp. All Rights Reserved.

Professional investment research since 2003

Home
Research
Get Access
Sign In
Company ProfileNOMAD Power Solutions, Inc.
  • Company Overview
  • FRC Research
  • Financial Data
  • Peer Comparison
  • Ownership & News
  • Discussion
NMAD
NOMAD Power Solutions, Inc. Stock AnalysisComprehensive stock analysis for NOMAD Power Solutions, Inc. (NMAD) including live price, Snowflake performance metrics, financial statements, and investment research.Stock AnalysisNMAD
NMAD
NOMAD Power Solutions, Inc.
  • Company Overview
  • FRC Research
  • Financial Data
  • Peer Comparison
  • Ownership & News
  • Discussion
NMAD
Home🔹Stocks🔹NOMAD Power Solutions, Inc.

NOMAD Power Solutions, Inc.

🇺🇸NMAD•NASDAQ

NOMAD Power Solutions, Inc.

🇺🇸NMAD•NASDAQ
Market cap
$44.25M
Sentiment

Your view on NMAD

Mkt Cap
$44.25M
Sentiment
Your view
Company Overview

Overview

What the company does, where it operates, and who runs it.

About NOMAD Power Solutions, Inc.

Industry
Biotechnology
Sector
Healthcare
CEO
Geordan G. Pursglove
Headquarters
680 East Colorado Boulevard, Boca Raton, FL, US
Industry
Biotechnology
Sector
Healthcare
CEO
Geordan G. Pursglove
Headquarters
680 East Colorado Boulevard, Boca Raton, FL, US
Description

Lixte Biotechnology Holdings, Inc. is a clinical-stage biopharmaceutical company, which engages in the business of developing a drug class called protein phosphatase 2A inhibitors.

The firm is also involved in utilizing biomarker technology to identify enzyme targets associated with serious common diseases and then designing novel compounds to attack those targets. The company was founded by John S. Kovach and Robert B. Royds on May 24, 2005 and is headquartered in Boca Raton, FL.

FRC Research

Media

Infographics, videos, and posts covering the company.

Financial Data

Stock Data

Price chart, volume, and trading data.

Fair Value

What FRC thinks it is worth vs. the current price.

FRC's fair value estimate for NOMAD Power Solutions, Inc., and the rating behind it. NMAD last traded at $3.58; the estimate is read against that market price. FRC analysts run the firm's valuation model across the companies on this platform to estimate what each one is worth, rather than republishing a consensus average. Shows the current estimate, our rating, and when it was last revised. A free account covers 7 company valuations a month; a paid subscription is unlimited.

Financial Ratios

Profitability, returns, valuation, and leverage ratios.

Valuation, profitability, liquidity and leverage ratios for NOMAD Power Solutions, Inc.. Starting points for NOMAD Power Solutions, Inc.: EPS -$0.64, beta 1.31 — an Biotechnology name. P/E, P/B, EV/EBITDA, margins, return on equity, current ratio and debt coverage, each shown against the company's own history.

Dividend Analysis

Yield, payout ratio, and dividend coverage metrics.

Dividend history, yield and payout sustainability for NOMAD Power Solutions, Inc.. NOMAD Power Solutions, Inc. does not currently pay a regular dividend, so this section tracks capacity rather than history. Per-share payments, yield over time, payout ratio and growth streak, with coverage measured against free cash flow.

Earnings Analysis

EPS history, beat rate, and upcoming earnings reports.

Reported vs. expected earnings history for NOMAD Power Solutions, Inc.. Trailing twelve-month EPS for NOMAD Power Solutions, Inc. stands at -$0.64. EPS surprises by quarter, revenue against estimates, and the upcoming reporting date.

Financial Statements

Income statement, balance sheet, and cash flow statements.

Income statement, balance sheet and cash flow history for NOMAD Power Solutions, Inc.. NOMAD Power Solutions, Inc. has reported as a listed company since 2020. Annual and quarterly filings with period-over-period comparison, so you can trace how revenue, margins and cash generation have moved.

Peer Comparison

Comparables

List of peer companies in the same industry.

NOMAD Power Solutions, Inc. valued side by side against its closest peers. NOMAD Power Solutions, Inc. is measured against Biotechnology peers within the Healthcare sector. Peer-relative multiples and operating metrics, so the valuation is read in the context of its own sector rather than in isolation.

Ownership & News

Institutional Ownership

Premium

Which funds and firms own the stock.

Which institutions hold NOMAD Power Solutions, Inc., and how their positions are changing. At a $44.2M market value, institutional positions materially move NOMAD Power Solutions, Inc.'s register. Top holders, position sizes, and quarter-over-quarter accumulation or distribution from regulatory filings. Included with FRC Premium.

Insider Trading

Premium

Recent buying and selling by company executives.

Buying and selling by NOMAD Power Solutions, Inc. executives and directors. Shares of NOMAD Power Solutions, Inc. have traded between $2.36 and $8.38 over the past 52 weeks — context for the timing of the transactions below. Insider transactions as disclosed to regulators, with role, size and date — the clearest read on how the people running the company are positioned. Included with FRC Premium.

Senate Trading

Premium

U.S. Senator disclosures filed under the STOCK Act.

U.S. Senate disclosures naming NOMAD Power Solutions, Inc.. NOMAD Power Solutions, Inc. is a $44.2M Healthcare company. Senators' reported transactions in this security, alongside the fundamentals — a signal most research platforms leave out entirely. Included with FRC Premium.

House Trading

Premium

U.S. Representative disclosures filed under the STOCK Act.

U.S. House of Representatives disclosures naming NOMAD Power Solutions, Inc.. Representatives' reported transactions in this security, shown next to the company's fundamentals. Included with FRC Premium.

News

Latest headlines and market coverage.

Latest headlines and company announcements for NOMAD Power Solutions, Inc.. Coverage tracks NOMAD Power Solutions, Inc. within Biotechnology (Healthcare). Press releases and market coverage, newest first.

Discussion

Comments

Comments and replies from FRC members about this company.

More Biotechnology companies

  • VINCVincerx Pharma, Inc.
  • VIRVir Biotechnology, Inc.
  • VIVSVivoSim Labs, Inc.
  • VKTXViking Therapeutics, Inc.
  • VNDAVanda Pharmaceuticals Inc.
  • VORVor Biopharma Inc.
  • VPROViropro Inc.
  • VRAXVirax Biolabs Group Limited
  • VRCAVerrica Pharmaceuticals Inc.
  • VRCIVerde Science, Inc.
  • VRDNViridian Therapeutics, Inc.
  • VRPXVirpax Pharmaceuticals, Inc.

ETFs holding NOMAD Power Solutions, Inc.

Largest holders, then the funds most concentrated in NMAD · % = share of the fund

  • VTIVanguard Total Stock Market ETF0.00%
  • VXFVanguard Extended Market ETF0.00%
  • VUN.TOVanguard U.S. Total Market Index ETF0.00%
  • VEQT.TOVanguard All-Equity ETF Portfolio0.00%
  • VGRO.TOVanguard Growth ETF Portfolio0.00%
  • VBAL.TOVanguard Balanced ETF Portfolio0.00%
  • VUS.TOVanguard U.S. Total Market Index ETF (CAD-hedged)0.00%
  • VCNS.TOVanguard Conservative ETF Portfolio0.00%

News

Latest Market News